Drug consumption facilities: An update since 2000

Drug and Alcohol Review

Volumn 22, Issue 2, 2003, Pages 227-233

  Kimber, Jo ^a   Dolan, K ^a   Van Beek, I ^b   Hedrich, D ^c   Zurhold, H ^d  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Sydney Medically Supervised Injecting Centre   (Australia)

^c EUROPEAN MONITORING CENTRE FOR DRUGS AND DRUG ADDICTION   (Portugal)

^d UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NARCOTIC AGENT;

DRUG MONITORING; HUMAN; INTERNATIONAL COOPERATION; MANAGEMENT; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PATIENT CARE; REVIEW; SOCIAL CARE; STANDARD;

DRUG MONITORING; HUMANS; INTERNATIONAL COOPERATION; NARCOTICS; PATIENT CARE TEAM; POLICY MAKING; PUBLIC ASSISTANCE;

EID: 0042911601     PISSN: 09595236     EISSN: None     Source Type: Journal    
DOI: 10.1080/095952301000116951     Document Type: Review

References (75)

1. Dolan K, Kimber J, Fry C, Fitzgerald J, MacDonald D, Trautmann F. Drug consumption facilities in Europe and the establishment of supervised injecting centres in Australia. Drug Alcohol Rev 2000;19:337-46.
2. Schneider W, Stöver H. Guidelines for the operation and use of consumption rooms. Materialien no. 4. Münster: Akzept e.V & Carl von Ossietzky Universität Oldenburg; May 2000.
3. Stoever H. Consumption rooms - a middle ground between health and public order concerns. J Drug Issues 2002;22(Spring):597-697.
4. Chitwood D, McCoy C, Incardi J et al. HIV seropositivity of needles for shooting galleries in South Florida. Am J Public Health 1990;80:150-152.
5. Carlson R. Shooting galleries, dope houses, and injection doctors: examining the social ecology of HIV risk behaviors among drug injectors in Dayton, Ohio. Hum Org 2000;59:325-333.
6. Parliament of New South Wales. Report on the establishment or trial of safe injecting rooms. Joint Select Committee into Safe Injecting Rooms. Sydney: Parliament of New South Wales, 1998.
7. Farrell M, Hall W. Swiss Heroin trials: testing alternative approaches. Br Med J 1998;317:639.
8. Kerr T, Palepu A. Safe injection facilities in Canada: Is it time? Can Med Assoc J 2001;165:439-7.
9. Broadhead RS, Kerr TH, Grund J, Altice FL. Safer injection facilities in North America: their place in public policy and health initiatives. J Drug Issues 2002;32:329-55.
10. Skretting A. Public injection rooms, a help to heroin addicts? Nord Alk Narkotikatidskr [English supplement] 2002;19:33-49.
11. Balotta D. Recent developments in the ELDD: new action plan on drugs in Norway. Drugnet Europe 2002;38:5.
12. Fischer B, Rehm J, Kim G, Robins A. Safer Injection Facilities (SIFs) for Injection Drug Users (IDUs) in Canada. Can J Public Health 2002;93:336-8.
13. Campbell W, el-Guebaly N. Safer injection facilities for injection drug users: the debate continues [letters]. Can Med Assoc J 2002;166:421.
14. Vlaming S. Safer injection facilities for injection drug users: the debate continues [letters]. Can Med Assoc J 2002;166:419.
15. Latowsky M. Safer injection facilities for injection drug users: the debate continues [letters]. Can Med Assoc J 2002;166:419-20.
16. Brock G, Gurekas V. Safer injection facilities for injection drug users: the debate continues [letters]. Can Med Assoc J 2002;166(4):420-1.
17. Elliot R, Malkin I, Gold J. Establishing safe injection facilities in Canada: legal and ethical issues. Can HIV/AIDS Policy Law Rev 2002;6:7-9.
18. Committee on Non-Medical Use of Drugs. Final Report of the Special Committee on Non-Medical Use of Drugs. Ottawa: Parliament of Canada; 2002. URL: http://www.parl.gc.ca/InfoComDoc/37/2/SNUD/Studies/Reports/snudrp01/16-ch5-e.htm #18 [accessed 13/2/03].
19. Programme DSaCS. Application for an exemption under Section 56 of the Controlled Drugs and Substances Act for a Scientific Purpose for a Pilot Supervised Injection Site Research Project Interim Guidance Document. Ottawa: Health Canada, 2002.
20. Basu A. Canada: Safe-injection sites to get federal OK. Winnipeg Free Press 2002; 10 November.
21. Kerr T. Inching closer to safe injection sites? Living + (British Columbia Persons with AIDS Society), 2002.
22. Crosbie J. Minister review proposal for heroin addicts. Irish Times 2000;5 September.
23. House of Commons Home Affairs Committee. The government's drug policy: is it working? London: Stationary Office, 2002.
24. Malinowski A. The vein in Spain: viability of safe injecting rooms. Druglink 2002; 17:20-22.
25. Zábransk T, Radimeck J, Mravcík V et al. Vrocní zpráva o stavu ve vecech drog 2001 [Annual Report on Drug Situation 2001 - Czech Republic]. Prague/Lisbon: Národní monitorovací stredisko pro drogy a drogové závislosti and EMCDDA, 2002.
26. Hedrich D. Experts discuss supervised consumption facilities. Drugnet Europe 2002;38:3.
27. Hedrich D. European Report on Drug Consumption Rooms. Lisbon: European Monitoring Centre Drugs and Drug Addiction (EMCDDA); In press.
28. International Narcotics Control Board. Report of the International Narcotics Control Board for 2001. Vienna: United Nations, 2002.
29. International Narcotics Control Board. Report of the International Narcotics Control Board for 1999. New York: United Nations, 2000.
30. Board INC. Report of the International Narcotics Control Board. Vienna: United Nations, 2001.
31. Hagan H. Supervised injection rooms - prospects and limitations. Int J Drug Policy 2002;13:449-51.
32. Wierling M. Fixerstuben, Druckräume, Konsumräume: Brennpunkte akzeptanzorientierter Drogenarbeit. Münster: INDRO e.V., 2002.
33. Malkin I. Establishing supervised injecting facilities: a responsible way to help minimise harm. Melbourne Univ Law Rev 2001;25:680.
34. Wood E, Kerr T, Spittal P et al. The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users. J Acq Immune Def Syndromes 2003;32:3-8.
35. Kelly C, Conigrave K. The Sydney medically supervised injecting centre: a controversial public health measure. Aust NZ J Public Health 2002;26:552-4.
36. Kimber J, van Beek I. Consumption rooms: the Australian experience. Akzeptanz 2003;10:54-8.
37. International Harm Reduction Association. Programme and abstract book: 11th International Conference on the Reduction of Drug Related Harm. Jersey, United Kingdom, 2000.
38. International Harm Reduction Association. Programme and abstract book: 12th International Conference on the Reduction of Drug Related Harm. New Dehli, India, 2001.
39. International Harm Reduction Association. Book of abstracts: 13th International Conference on the Reduction of Drug Related Harm. Ljubljana, Slovenia, 2002.
40. Biesma S, Meijer G, Bieleman B. Opgevangen in het centrum: Evauatie opvangen adviescentrum Apeldoorn. Groningen-Rotterdam: INTRAVAL, 2000.
41. Graff I, Linssen L, Wolf J. Gebruiksruimten in Nederland. Passage 2001;10:86-95.
42. Linssen L, de Jong W, Wolf J. Gebruiksruimten: Een systematisch overzicht van de voorziening en de effecten ervan. Utrecht: Trimbos-Instituut, ontwikkelcentrum Social Verslavingsbeleid, 2000.
43. Linssen L, Graff I, Wolf J. Gebruiksruimeten in beeld: Handrieking bij de organisatie enrichtung. Utrecht: Trimbos Institut, 2002.
44. Meijer G, de Jong A, Koeter M, Bieleman B. Gebruik van de straat: Evaluatie gebruiksruimte binnenstad-Zuid Groningen. Groningen-Rotterdam: INTRAVAL, 2001.
45. Baumgärtner T. Welche Auswirkungen haben die geänderten Drob-Inn-GR-öffnungszeiten auf das Nutzungsverhalten der Besucherinnen dieser und der dezentralen Enrichtungen? Statistische Auswertungen der Prä- und Post-Samstags-Schließungs-Befragungen unter GR-Nutzer-Innen in Hamburg. Hamburg: Institut für Interdisziplinäre Sucht- und Drogenforschung (ISO), 2000.
46. Behörde für Arbeit GuSH-RDuS. Drogenkonsumräume Evaluation 1999/2000. Hamburg: Behörde für Arbeit, Gesundheit und Soziales Hamburg-Referat Drogen und Sucht, 2001.
47. Gessenharter W. Mediatorenverfahren "Weitere Gesundheitsräume in St. Georg? Wunschbarkeit, Zweckmäßigkeit, Notwendigkeit" Abschlußbericht des Mediators. Hamburg: Senat der Freien und Hansestadt Hamburg, 1999.
48. Happel HV. Konsumräume: Eine effective Maßnahme zur Schadensminimierung bei Drogenbraucherlnnen und Bürgerinnen. Frankfurt: Fachhochschule Frankfurt/M., 1999.
49. Stöver H. Konsumräume: Zwischenbilanz und Anforderungen an Weiterentwicklung und Qualitätsicherung. In: Böllinger L, Stöver H, editors. Drogenpraxis, Drogenrecht, Drogenpolitik. Frankfurt am Main: Fachhochschulverlag, 2002:174-89.
50. Happel V, Steinmetz J. Ueberdosierungen im Konsumraum: Ergebnisse und Erfahrungen nach fünfjähriger Begleitung des grössten Frankfurter Konsumraums. In: e.V A, ed. Gesellschaft mit Drogen-Akzeptanz im Wandel. Berlin: VWB, 2001:189-95.
51. Benninghoff F, Geense R, Dubois-Arber F. Resultate der Studie "Klienten niederschwelliger Anlaufstellen in der Schweiz: Basel (Gassenzimmer I, II, und K&A Eskamed)" Geneve (BIPS), Sienne (Drop-In/Cardinal): Lausanne Institut Universiteaire de Medicine Sociale e Preventive, 2001.
52. Eastus C. Die Entwicklung von Gesundheitsräumen in der Schweiz. Akzeptanz 2000;1:10-12.
53. Zurhold H. Drogenkonsumräume im Spannungsfeld zwischen gesundheitspolitischen und ordnungspolitischen Wirkungserwartungen. Akzeptanz 2001;2.
54. MSIC Evaluation. Eighteen-month process evaluation report on the medically supervised injecting centre. Sydney: University of New South Wales, 2002.
55. Gerlach R, Schneider W. Injecting Room at INDRO, Münster, Germany: some key information and experiences-revised and updated internet version. Münster: INDRO e.V., 2002.
56. Ronco C, Spuhler G, Coda P, Schopfer R. Evaluation der Gassenzimmer I, II und III in Basel. Sozial und Praventivmedizin 1996;41:S58-68.
57. Poschadel S, Höger R, Schnitzler J, Schreckenberg D. Evaluation der Arbeit der Drogenkonsumräume in der Bundesrepublik Deutschland: Bochum: Zentrum für angewandte Psychologie, Umwelt-und Sozialforschung (ZEUS), 2002.
58. Jacob J, Rottman J, Stöver H. Entstehung und Praxis eines Gesundheitsraumangebotes für Drogenkonsumierende. Abschlußbericht der einjährigen Evaluation des 'drop-in Fixpunkt', Hannover. Oldenburg: Bibliotheks -und Informationssystem der Universität Oldenburg, 1999.
59. Biesma S, Bieleman B. Keetje Tippel gebruikt. Evaluatie van gebruiksruimte de Buren bij Keetje Tippel te Rotterdam. Groningen-Rotterdam: INTERVAL, 1998.
60. Biesma S, Bieleman B. Ruimet om te gebruiken: Evaluatie gebruiksruimte Spanjaardstraat Rotterdam. Groningen-Rotterdam: INTRAVAL, 1998.
61. Biesma S, Bieleman B. De Daeke in gebruik. Evaluatie Opvang en Adviescentrum en gebruiksruimte De Daike in Venlo. Groningen-Rotterdam: INTRAVAL, 1998.
62. Geense R. Evaluation of the Federal measures to reduce the problems related to drug use. To have or to have not: that's the question. A qualitative study on four low threshold needle exchange service for drug users in Switzerland. [Masters of Public Health]. Lausanne: University Institute of Social and Preventative Medicine, 1997.
63. Kemmesies UE. The open drug scene and the safe injection room offers in Frankfurt am Main 1995. Frankfurt: Stadt Frankfurt/Dezernat Frauen und Gesundheit, Drogenreferat, 1999.
64. Bundesministerium für Gesundheit und Soziale Sicherung, editor. Evaluation der Arbeit von Drogenkonsumräumen in der Bundesrepublik Deutschland. Baden-Baden: Nomos, 2003.
65. MSIC Evaluation. Evaluation Protocol for the trial a Medically Supervised Injecting Centre in Kings Cross. Sydney: University of New South Wales, 2001.
66. Fry C. Injecting drug user attitudes towards rules for supervised injecting rooms: implications for uptake. Int J Drug Policy 2002;13:471-6.
67. Homann B, Paul B, Thiel G, Warns M. Drug consumption patterns and the need of drug consumption rooms in the open drug scene of Hamburg [abstract]. Sucht 2000;46:129-36.
68. van Beek I, Gilmour S. Preference to have used a medically supervised injecting centre among injecting drug users in Kings Cross, Sydney. Aust NZ J Public Health 2000;24:540-2.
69. Spinal P, Craib K, Wood E et al. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. Can Med Assoc J 2002;166:894-9.
70. Miller C, Johnston C, Spittal P et al. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of injecting drug users. Hepatology 2002;36.
71. MSIC Evaluation. Twelve-month process evaluation report on the medically supervised injecting centre. Sydney: University of New South Wales, 2002 May.
72. Gerlach R, Schneider W, Consumption and injecting room (CIR) at INDRO, Münster, Germany: Annual Report 2002 [English version]. Münster: INDRO e.V., 2003.
73. Kimber J, Dolan K, Wodak A. International survey of supervised injecting centres (1999-2000). NDARC Technical Report 126. Sydney: University of New South Wales, 2001.
74. Grand J-P. Drug use as a social ritual-functionality, symbolism and determinants of self-regulation. Rotterdam: University of Rotterdam, 1993.
75. Higgs P, Mäher L, Jordens J, Dunlop A, Sargent P. Harm reduction and drug users of Vietnamese ethnicity. Drug Alcohol Rev 2001;20:239-45.